CVS Health Corp(CVS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 25.18 | EPS (ttm) | 3.79 | Insider Own | 0.16% | Shs Outstand | 1.28B | Perf Week | -2.27% |
| Market Cap | 121.99B | Forward P/E | 11.21 | EPS next Y | 6.35% | Insider Trans | -62.71% | Shs Float | 1.28B | Perf Month | -0.3% |
| Enterprise Value | 184.53B | PEG | 0.87 | EPS next Q | 1.63 | Inst Own | 91.67% | Short Float | 1.32% | Perf Quarter | -1.73% |
| Income | 4.89B | P/S | 0.29 | EPS this Y | 18.55% | Inst Trans | 1.17% | Short Ratio | 2.16 | Perf Half Y | 24.97% |
| Sales | 415.11B | P/B | 1.53 | EPS next 5Y | 12.89% | ROA | 1.91% | Short Interest | 16.82M | Perf YTD | 20.19% |
| Book/sh | 62.36 | P/C | 8.74 | EPS past 3/5Y | -24.7% -23.94% | ROE | 6.23% | 52W High | -13.82% ($110.68) | Perf Year | 32.93% |
| Cash/sh | 10.91 | P/FCF | 10.37 | Sales past 3/5Y | 7.6% 8.4% | ROIC | 3.21% | 52W Low | 37.22% ($69.51) | Perf 3Y | 44.87% |
| Dividend Est. | $2.73 (2.86%) | EV/EBITDA | 9.6 | EPS Y/Y TTM | 6.51% | Gross Margin | 14.16% | Volatility(W/M) | 2.06% 2.04% | Perf 5Y | 11.67% |
| Dividend TTM | 2.66 | EV/Sales | 0.44 | Sales Y/Y TTM | 7.41% | Oper. Margin | 3.54% | ATR (14) | 2.38 | Perf 10Y | 4.22% |
| Dividend Ex-Date | 2026/7/23 | Quick Ratio | 0.66 | EPS Q/Q | 187.93% | Profit Margin | 1.18% | RSI (14) | 45.36 | Recom | 1.5 |
| Dividend Gr. 3/5Y | 5.74% 5.87% | Current Ratio | 0.87 | Sales Q/Q | 7.24% | SMA20 | 0.53% ($94.88) | Beta | 0.58 | Target Price | $114.58 |
| Payout | 191.23% | Debt/Eq | 0.96 | Earnings | 2026/8/5 | SMA50 | -5.06% ($100.46) | Rel Volume | 0.78 | Prev Close | $96.07 |
| Employees | 300000 | LT Debt/Eq | 0.91 | EPS/Sales Surpr. | 39.14% 6.07% | SMA200 | 9.96% ($86.74) | Avg Volume(3M) | 7.79M | Price | $95.38 |
| IPO | 1952/10/1 | Option/Short | Yes/Yes | Trades | 46896 | Volume | 6,077,850 | Change | -0.72% |
Company
CVS is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
💊 An integrated healthcare company with a nationwide network of pharmacies and health clinics across the U.S., also operating prescription drug benefits management and health insurance (Aetna). Headquartered in Woonsocket, Rhode Island, its core strength lies in a vertically integrated model that combines pharmacies, drug pricing management, insurance, and primary care.
Over the past 1 year, roughly in the middle
14% below its 1-year high.
CVS has weak earning power
Review management risk carefully before investing
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +18.6% this year.
Tap to view numbers
The stock looks undervalued
Trading at 25.2 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Would have changed by +44.9% if bought 5 years ago.
Tap to view numbers
Dividends are paid consistently
Pays 2.86% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 91.7%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
IHF 0.15%
MFVL 0.06%
ROPE 0.05%
RTH 0.05%
DUSA 0.05%It ranks #2 in the industry
Based on market cap of $122B.
CVS $122B PER 25.2
UNH $353B PER 25.3
ELV $86B PER 17.6
CI $74B PER 11.5
실적분석 · 8/5 CVS Health ($CVS) Q2 2026 Earnings Analysis — Adjusted EPS Significantly Beats, Full-Year Guidance Raised 투자 가이드 · 4/11 The Complete 2026 Guide to U.S. Dividend Aristocrats 투자 가이드 · 4/1 US Stock Taxes Complete Guide 2026 — Calculation Methods and Tax-Saving Strategies for Beginners See all posts on this stock FAQ
What kind of company is CVS?
CVS belongs to the Healthcare sector and operates in the Healthcare Plans industry.
What is the market cap of CVS?
The market cap of CVS is approximately $122.0B, ranking 128 within its sector.
Does CVS pay dividends?
CVS has a dividend yield of approximately 2.86%, with an annual dividend of $2.73.
What is the P/E ratio of CVS?
CVS has a P/E ratio of approximately 25.2x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for CVS?
CVS has recorded a 52-week high of $110.68 and a low of $69.51.
